The regulation and coordination of mitochondrial metabolism with hematopoietic stem cell (HSC) self-renewal and differentiation is not fully understood. Here we report that depletion of PTPMT1, a PTEN-like mitochondrial phosphatase, in inducible or hematopoietic-cell-specific knockout mice resulted in hematopoietic failure due to changes in the cell cycle and a block in the differentiation of HSCs. Surprisingly, the HSC pool was increased by $40-fold in PTPMT1 knockout mice. Reintroduction of wild-type PTPMT1, but not catalytically deficient PTPMT1 or truncated PTPMT1 lacking mitochondrial localization, restored differentiation capabilities of PTPMT1 knockout HSCs. Further analyses demonstrated that PTPMT1 deficiency altered mitochondrial metabolism and that phosphatidylinositol phosphate substrates of PTPMT1 directly enhanced fatty-acid-induced activation of mitochondrial uncoupling protein 2. Intriguingly, depletion of PTPMT1 from myeloid, T lymphoid, or B lymphoid progenitors did not cause any defects in lineage-specific knockout mice. This study establishes a crucial role of PTPMT1 in the metabolic regulation of HSC function.
SUMMARY
The regulation and coordination of mitochondrial metabolism with hematopoietic stem cell (HSC) self-renewal and differentiation is not fully understood. Here we report that depletion of PTPMT1, a PTEN-like mitochondrial phosphatase, in inducible or hematopoietic-cell-specific knockout mice resulted in hematopoietic failure due to changes in the cell cycle and a block in the differentiation of HSCs. Surprisingly, the HSC pool was increased by $40-fold in PTPMT1 knockout mice. Reintroduction of wild-type PTPMT1, but not catalytically deficient PTPMT1 or truncated PTPMT1 lacking mitochondrial localization, restored differentiation capabilities of PTPMT1 knockout HSCs. Further analyses demonstrated that PTPMT1 deficiency altered mitochondrial metabolism and that phosphatidylinositol phosphate substrates of PTPMT1 directly enhanced fatty-acid-induced activation of mitochondrial uncoupling protein 2. Intriguingly, depletion of PTPMT1 from myeloid, T lymphoid, or B lymphoid progenitors did not cause any defects in lineage-specific knockout mice. This study establishes a crucial role of PTPMT1 in the metabolic regulation of HSC function.
INTRODUCTION
Mitochondria are highly dynamic organelles that play multiple important roles in cells (Balaban et al., 2005) . As the site of respiration/oxidative phosphorylation, these double-membrane organelles provide a highly efficient route for eukaryotic cells to generate ATP from energy-rich molecules. The role of the mitochondria in ATP generation is dependent on ambient oxygen tension. Under normal oxygen tensions, cells catabolize glucose to pyruvate. Pyruvate is then imported into the mitochondria for further catabolism through the Krebs cycle, which transfers electrons to the respiratory chain for ATP synthesis. In low oxygen tensions, or hypoxic conditions where there is a lack of oxygen as an electron acceptor, cells undergo anaerobic glycolysis as a default mode. Pyruvate is then used for low-efficiency energy production in the cytosol by glycolysis. Mitochondrial energy metabolism is regulated by multiple mechanisms. Uncoupling proteins (UCPs), especially UCP1, in the mitochondrial inner membrane attenuate mitochondrial energy production by conducting proton leak from the intermembrane space to the matrix and dissipating the proton gradient necessary for ATP generation (Brand and Esteves, 2005; Krauss et al., 2005) . The functions of other UCPs, however, are still controversial. Emerging evidence suggests that UCP2 may regulate cellular bioenergetics by controlling mitochondrial substrate utilization. Specifically, increased UCP2 activity inhibits pyruvate entering into the mitochondria for Krebs cycle utilization while facilitating the oxidation of alternative carbon sources, such as fatty acids and glutamine (Bouillaud, 2009; Diano and Horvath, 2012; Samudio et al., 2009) .
The function of mitochondria in the coordination of hematopoietic stem cell (HSC) maintenance and lineage differentiation is not well defined (Mantel et al., 2011; Suda et al., 2011) . The ambient oxygen tension in the microenvironment (niches) of HSCs is believed to be low. To produce ATP in this environment, HSCs utilize glycolysis instead of mitochondrial oxidative phosphorylation for energy production (Simsek et al., 2010) . Limited mitochondrial aerobic metabolism in HSCs helps to preserve this essential cell reservoir from oxidative damage by attenuating the production of reactive oxygen species (ROS), a byproduct generated during mitochondrial oxidative phosphorylation. A recent study has demonstrated that the mitochondrial content in HSCs is even slightly higher than that in myeloid progenitors, although lower than that in late erythroid progenitors (Norddahl et al., 2011) , indicating that mitochondria in HSCs are relatively inactive. However, when HSCs undergo differentiation, a robust energy demand is expected for this rapid and energy-consuming cellular process. Indeed, ATP and ROS levels in lineagecommitted progenitors are much higher than those in HSCs (Inoue et al., 2010; Simsek et al., 2010) . Nonetheless, how mitochondrial energy metabolism is regulated and how mitochondrial bioenergetics and substrate utilization cooperatively coordinate both HSC differentiation and self-renewal in concert with other mechanisms is poorly understood.
PTPMT1, a PTEN-like phosphatase encoded by nuclear DNA, is relatively widely expressed in various tissues and is exclusively localized to the inner membrane of mitochondria via N-terminal amino acids 1-37 (Pagliarini et al., 2005) . Little is known about the role of PTPMT1 in physiology and disease; however, recent studies have shown that global disruption of PTPMT1 results in developmental arrest and postimplantation lethality (Shen et al., 2011; Zhang et al., 2011a) due to the block of embryonic stem cell (ESC) differentiation (Shen et al., 2011) . To further dissect the physiological function of PTPMT1, we have created a PTPMT1 conditional allele (PTPMT1 fl/+ ) and determined the effects of PTPMT1 depletion on hematopoietic cell development. (Kü hn et al., 1995) . Four-week-old PTPMT1 fl/fl /Mx1-Cre + mice were treated with pI-pC to induce Cre expression and PTPMT1 deletion. As a result, nearly 80% of the mice died within 2-3 weeks of treatment ( Figure 1B ) due to pancytopenia and severe anemia ( Figure S1D ). Moreover, bone marrow (BM) myeloid ( Figure 1C ) and lymphoid ( Figure 1D ) progenitors detected by colony-forming unit (CFU) assays were drastically decreased as compared with those in control mice. Twenty percent of pI-pC-treated PTPMT1 fl/fl /Mx1-Cre + mice survived owing to the incomplete deletion of PTPMT1 in HSCs and the reconstitution of hematopoiesis from PTPMT1-undeleted HSCs. As shown in Figure 1E , 7 days after pI-pC treatment, a majority of peripheral blood cells showed PTPMT1 deletion (representing direct deletion from these cells Figure 1F) . Surprisingly, the percentage of HSCs in the BM of these mice was increased by $40-fold ( Figure 1G ) (absolute numbers are shown in Table S1 increased by 2.8-to 11-fold ( Figure 1G ). Remarkably, even 12 months after PTPMT1 ablation, the number of HSCs ($90% of which exhibited PTPMT1 depletion) in the knockout mice were still $27 times greater than that in control mice ( Figure S1E ). The drastic expansion of the stem cell pool implies that hematopoietic failure caused by PTPMT1 ablation from the mitochondria was not due to an induction of apoptosis. In fact, apoptotic cells in HSCs were not appreciably changed in PTPMT1 knockout mice ( Figure 1H ). anemia within 5-9 days of birth ( Figure 2A ). These animals could be completely rescued by receiving transplants of wild-type (WT) BM cells (Figure 2A ), verifying the cell-autonomous effect of PTPMT1 deficiency on neonatal hematopoiesis. Autopsies of PTPMT1 fl/fl /Vav1-Cre + pups revealed that the sizes of the spleen and the thymus were drastically decreased compared with those of WT littermates ( Figure 2B ). Histopathological examination of BM cells confirmed hematopoietic failure ( Figure 2C ). Total cell numbers of the BM from PTPMT1 fl/fl /Vav1-Cre + neonates were decreased by $75-fold at postnatal day 5 (P5) ( Figure S2A ). Hematopoietic progenitors in the BM of knockout mice were undetectable ( Figure 2D ). Figure 2E ; PTPMT1 was completely deleted in these cells; data not shown), fully consistent with the stem cell effects in inducible adult PTPMT1 knockouts ( Figure 1G ). The expansion of HSCs in PTPMT1 fl/fl /Vav1-Cre + mice appeared to be developed gradually ( Figure S2B ). Notably, apoptosis in the BM cells ( Figure S2C ) and levels of ROS ( Figure S2D ) that are often elevated and cause cell death when mitochondria are dysfunctional were not altered.
RESULTS

PTPMT1
Differentiation and Repopulating Capabilities of HSCs
Are Blocked in the Absence of PTPMT1 Since HSCs were drastically expanded and MPPs were increased to a much lesser extent, hematopoietic failure in PTPMT1 knockout mice appeared to be caused mainly by a block in the differentiation of stem cells. To test this hypothesis, HSCs were purified from PTPMT1-depleted mice and assessed for various functional activities. In response to cytokine stimulation, PTPMT1 knockout stem cells failed to differentiate to produce colonies in CFU assays ( Figure 3A ). primary recipients 20 weeks after pI-pC administration and examined PTPMT1 deletion in these cells. As shown in Figure 3F , Colonies were counted 12 days later.
(B) Sorted HSCs were individually deposited into 96-well plates and cultured in Thrombopoietin (TPO) (50 ng/ml), Flt3 ligand (50 ng/ml), stem cell factor (SCF) (50 ng/ml), IL-3 (25 ng/ml), and IL-6 (20 ng/ml) containing medium for 7 days. ) cell populations in primary recipient mice (n = 5/group) were quantified by multiparameter FACS analyses 20 weeks following pI-pC treatment. Data shown in (A) and (C)-(G) are presented as mean ± SD. Also see Figure S3 . were still four to six times greater than those in control testcell-derived populations in primary recipients (Figures 3G and S3E) , reaffirming the profound cell-autonomous effects of PTPMT1 deficiency on stem/early progenitor cell homeostasis.
Catalytic Activity and Mitochondrial Localization Are Required for the Function of PTPMT1 in HSCs PTPMT1 is a phosphatase that is exclusively localized to the mitochondria (Pagliarini et al., 2005) . To elucidate the structural bases for the indispensable role of PTPMT1 in HSCs, WT PTPMT1, catalytically deficient PTPMT1 C132S, and truncated PTPMT1 lacking the mitochondrial localization signal (amino acids 1-37) (PTPMT1 D37) were transduced into PTPMT1 fl/fl / Mx1-Cre + BM cells through retroviral-mediated gene transfer.
Transduced cells were sorted according to green fluorescent protein (GFP) expressed separately by the retroviral vector, and then assessed for repopulating/differentiation capabilities by competitive repopulation assays, as described in Figure 3D . were transduced with either WT PTPMT1, PTPMT1 C132S, PTPMT1 D37, or control vector, and then assessed for radioprotective function in lethally irradiated recipient mice. As shown in Figure 4B , only WT PTPMT1-transduced knockout cells rescued recipient animals, whereas all transplants receiving either PTPMT1 C132S, PTPMT1 D37, or control-vector-transduced knockout cells invariably died within 2-3 weeks of irradiation.
Furthermore, the percentage of HSCs in WT PTPMT1-rescued recipients was restored to the normal range (data not shown). These add-back experiments, while confirming the crucial cellintrinsic role of PTPMT1 in HSCs, suggest that this phosphatase functions in a catalytically dependent manner and that the mitochondrial localization is required for its function. Figures S4A-S4C) , nor was the cell cycle of lineage progenitors altered ( Figure S4D ). The lineage-specific knockout mice were active and fertile without any discernible abnormalities during the 1.5 years of follow-up. These in vivo data strongly suggest that while PTPMT1 plays a vital role in stem cells, it is dispensable for late lineage progenitors. 
PTPMT1-Depleted
Cell Stem Cell
Mitochondrial Metabolic Regulation of Stem Cells knockout mice ( Figure S4E ). We also determined the expression of p16, a molecular hallmark of cellular senescence. Again, there were no significant changes in p16 levels between WT and knockout LSK cells ( Figure 5F ) or HSCs ( Figure S4F ). We then analyzed the cell cycle status of LSK cells and HSCs. These analyses revealed a significant increase in the percentages of knockout LSK cells and HSCs at the G 1 phase while the percentages of S/G 2 /M cells were not changed ( Figures 5A and 5B) . Moreover, the percentages of LSK cells and HSCs at the G 0 phase (quiescence) were decreased in PTPMT1-depleted mice. In vivo BrdU incorporation assays showed that after 16 hr of in vivo BrdU labeling, the percentages of BrdU + cells in LSK and HSC populations in PTPMT1 knockout mice were not significantly altered ( Figures 5C and 5D ), verifying the S phase data obtained from the dye-based cell cycle analyses ( Figures 5A and 5B). Furthermore, BrdU long-term label-retaining assays (Wilson et al., 2008) demonstrated that BrdU label-retaining cells in the HSC population in PTPMT1 knockout mice 100 days after the BrdU labeling were markedly decreased (Figure 5E ), reaffirming the loss of quiescence in PTPMT1 deficient HSCs. Collectively, these cell cycle data suggest an enhanced entry of quiescent stem cells (G 0 phase) into the cell cycle in PTPMT1 knockout mice, and that these cells were subsequently delayed at the G 1 phase (the ratio of S/G 2 /M cells to G 1 cells was decreased). In agreement with the cell cycle changes, p21 and p57, cyclin-dependent kinase inhibitors critical for controlling HSC cycling (Cheng et al., 2000; Matsumoto et al., 2011; Zou et al., 2011) , were significantly upregulated in PTPMT1-depleted stem cells and early progenitors ( Figure 5F ).
PTPMT1 Depletion Results in Defective Mitochondrial Aerobic Metabolism
We next sought to determine the fundamental impact of PTPMT1 ablation on the mitochondria. Ultra structures of mitochondria in PTPMT1-depleted stem cells were not altered (data not shown) and the overall mitochondrial DNA content in these cells was comparable to that in control cells ( Figure 6A ). Also, steady state total cellular ATP levels ( Figure 6B ) and ROS levels in PTPMT1-depleted HSCs ( Figure 6C) were not significantly changed. We next analyzed mitochondrial aerobic metabolism in intact, viable LSK cells using real-time measurement of oxygen consumption. PTPMT1 knockout cells had much lower basal oxygen consumption and maximal oxidative capacity as compared with WT cells ( Figure 6D ). Interestingly, measurement of extracellular proton flux revealed that PTPMT1-depleted cells had significantly increased extracellular acidification rates ( Figure 6E ), suggesting that these cells exhibited enhanced glycolysis. In agreement with these data on the mitochondrial function, AMP-activated kinase (AMPK), an intracellular energy sensor (Hardie, 2011) , was highly activated (determined by phosphorylation of Thr 172 ) in PTPMT1 knockout LSK cells ( Figure 6F ) and HSCs ( Figure 6G ). Acetyl-CoA carboxylase (ACC), one of the targets of AMPK and a negative regulator of fatty acid oxidation (Viollet et al., 2009) , was inhibited, as evidenced by the increase in the inhibitory phosphorylation of this enzyme ( Figure 6F ), implying that fatty acid metabolism might be enhanced in PTPMT1 knockout stem cells. Intriguingly, PTPMT1-depleted macrophages derived from myeloid-specific knockout (PTPMT1 +/+ /LysM-Cre + ) mice also showed decreased mitochondrial aerobic metabolism at basal levels and maximal reserve capacities ( Figure S5A ). However, no defects in the growth ( Figure S5B ) and the cell cycle ( Figure S5C ) were detected. Also, there was no upregulation of p53, p21, or p57 in these knockout macrophages ( Figure S5D ), and AMPK phosphorylation was only marginally increased in these cells ( Figure S5E ).
Excessive PIP Substrates of PTPMT1 Decrease Mitochondrial Aerobic by Enhancing UCP2 Activity PTPMT1 favors phosphatidylinositol phosphates (PIPs), especially PI(3,5)P 2 , PI5P, and PI(3,4)P 2 , as substrates (Shen et al., 2011) , similar to PTEN phosphatase. PIPs are a class of membrane phospholipids that regulate many important cellular processes, including membrane trafficking and ion channel/ transporter functions (Di Paolo and De Camilli, 2006; Gamper and Shapiro, 2007) . PTPMT1 is localized to the mitochondrial inner membrane (Pagliarini et al., 2005) where many ion channels/transporters, important for mitochondrial metabolism, reside. To determine the mechanisms of the altered mitochondrial function in PTPMT1-deficient cells, we assessed effects of overloading these PIP substrates on mitochondrial aerobic metabolism. Perfusion of PI(3,5)P 2 , PI(3,4)P 2 , or PI5P into WT LSK cells resulted in a significant reduction in oxygen consumption both at the basal level and at the maximal oxidative capacity ( Figures 7A and 7B ), recapitulating the metabolic changes of PTPMT1 knockout LSK cells ( Figure 6D ). These results indicate that PIP substrates accumulated due to the loss of dephosphorylation by PTPMT1 might account for the altered mitochondrial function in PTPMT1-depleted cells. We next sought to identify direct effector proteins of these PIPs. A recent study has shown that ectopic expression of mitochondrial UCP2 blocks ESC differentiation with no impact on cell survival (Zhang et al., 2011b) . Enhanced UCP2 activity impairs ESC differentiation by perturbing the metabolic transition from glycolysis to mitochondrial aerobic metabolism required for ESC differentiation (Zhang et al., 2011b) . PTPMT1 depletion also blocks ESC differentiation without affecting cell survival (Shen et al., 2011) . Similar effects caused by ectopic expression of UCP2 and PTPMT1 ablation prompted us to test for a potential link between PTPMT1 and UCP2. No differences in UCP2 mRNA levels were detected between WT and PTPMT1-depleted HSCs (data not shown). We then tested whether PTPMT1 PIP substrates might function as modulators of UCP2 activity using a UCP2-reconstituted planar lipid bilayer system. As shown in (A and B) PI(3,5)P 2 , PI5P, and PI(3,4)P 2 (di-C 16 ) (20 mM) were delivered (shuttled) into purified WT LSK cells using Shuttle PIP kits (Echelon Biosciences, Inc.). Cells were assessed for OCR. A representative figure is shown in (A) and statistical data are shown in (B). **p < 0.01. (C) Representative current-voltage characteristics of UCP2-containing membranes measured in the presence of PI(3,5)P 2 , arachidonic acid (AA), or both. Bilayer lipid membranes were made from E. coli polar lipid (1.8 mg/ml), AA (15 mol%), and hUCP2 (5 mg/mg lipid). Buffer solution contained 50 mM Na 2 S0 4 , 10 mM TRIS, 10 mM MES, and 0.6 mM EGTA (pH = 7.35), T = 32 .
(D) Comparison of membrane conductance in the absence or presence of PI(3,5)P 2 , PI5P, or PI(3,4)P 2 . All PIPs were added at 4 mM. Statistical data from three independent experiments are shown. (E) HSCs purified from PTPMT1 fl/fl /Mx1-Cre + mice 4 weeks after pI-pC treatment were cultured in SCF (50 ng/ml), IL-3 (25 ng/ml), and IL-6 (20 ng/ml) containing medium in the presence of PIKfyve inhibitor (YM201636) or DMSO (vehicle) for 7 days, immunostained for Mac-1 and B220, and then analyzed by FACS. Statistical data from three independent experiments are shown. Figures 7C and 7D, the addition of PI(3,5)P 2 , PI5P, or PI(3,4)P 2 , but not their precursor PI, enhanced fatty acid (arachidonic acid)-induced activation of UCP2. Total membrane proton conductance carried out by UCP2 was markedly increased by the addition of PI(3,5)P 2 , PI5P, and PI(3,4)P 2 . These in vitro electrophysiological data provide direct evidence that PIP substrates, which accumulate in PTPMT1-depleted mitochondria, can alter mitochondrial function by enhancing UCP activities. Finally, we reasoned that if excessive PIP substrates of PTPMT1, such as PI(3,5)P 2 , contributed to the mitochondrial dysfunction and thus the impaired differentiation of PTPMT1 knockout HSCs, then inhibition of PI(3,5)P 2 production would partially correct this problem. We treated purified PTPMT1 knockout HSCs with YM201636, a selective inhibitor of type III PIP kinase PIKfyve (Jefferies et al., 2008) that is responsible for the production of PI(3,5)P 2 . Indeed, cytokine-induced differentiation of PTPMT1 knockout HSCs toward Mac-1 + cells was largely restored in liquid culture by the PIKfyve inhibitor (Figure 7E) . Moreover, cytokine-induced colony formation of PTPMT1 knockout HSCs was also partially rescued ( Figure 7F ). Approximately 50% of the colonies formed in the YM201636-treated group were derived from PTPMT1-depleted HSCs while none of the colonies seen in the DMSO-treated group were generated from PTPMT1-deleted stem cells (they were derived from residual PTPMT1-undeleted cells) according to PCR genotyping results (data not shown). These rescue data provide further support to the notion that the differentiation block of PTPMT1 knockout stem cells is likely attributed to the accumulation of PTPMT1 PIP substrates.
DISCUSSION
By dissecting the role of mitochondrial phosphatase PTPMT1 in hematopoiesis, this study has revealed an essential mitochondrial metabolic regulation of HSC differentiation. HSCs contain similar numbers of mitochondria, as do myeloid progenitors (Norddahl et al., 2011) . However, stem cells utilize glycolysis instead of aerobic metabolism for energy production (Simsek et al., 2010) , suggesting that mitochondria are less active in these cells. In contrast, mitochondrial activities and ATP levels are much higher in lineage progenitors (Inoue et al., 2010; Simsek et al., 2010) , indicating a robust upregulation of mitochondrial bioenergetics during stem cell differentiation. We now provide evidence that PTPMT1 plays a critical role in priming mitochondria for this rapid metabolic transition. PTPMT1 depletion caused hematopoietic failure in mice ( Figures 1B, S1D , 2A, and 2B) and PTPMT1-depleted HSCs failed to differentiate in both in vitro ( Figures 3A, 3B , and S3A) and in vivo (Figures 3C, 3D, S3B, and S3C) settings. This appears to be attributed to the alterations of mitochondrial metabolism in these cells (Figure 6D) . Although steady state cellular ATP homeostasis was maintained in knockout stem cells ( Figure 6B ), this was likely due to a compensatory increase in alternative energy production pathways. Indeed, extracellular acidification rates, an indication of glycolysis, were elevated in PTPMT1-depleted cells ( Figure 6E ) and the activity of ACC, a negative regulator of fatty acid oxidation (Viollet et al., 2009) , was inhibited ( Figure 6F ). Interestingly, PTPMT1 regulation of mitochondrial bioenergetics appears to be selectively important for differentiation versus self-renewal in stem cells. Differentiation of PTPMT1 knockout HSCs was completely blocked (Figure 3 ), but these cells were still cycling in vivo. Although knockout stem cells were delayed at the G 1 phase, the percentage of S/G 2 /M cells was comparable to that of control cells. In addition, knockout stem cells lost quiescence (G 0 phase) (Figure 5 ). Since the stem cell pool in knockout mice was drastically expanded (Figures 1G and 2E ), these cell cycle changes caused by PTPMT1 ablation appear to mainly impact the differentiation-associated cycling while the cycling for stem cell self-renewal was less affected (PTPMT1-depleted HSCs failed to expand in vitro, likely because the culture conditions-cytokines, nutrients, oxidative stress, etc.-were not favorable). The underlying mechanism for this bias remains to be further determined.
Equally interesting is that PTPMT1 is required for the differentiation of stem cells and early progenitors but is not required for late lineage progenitor differentiation. S4D ). This suggests that PTPMT1 depletion has distinct effects in hematopoietic cells depending on the stage in which the cells are targeted. There appears to be a unique and specific requirement for mitochondrial energy metabolism for stem cell/early progenitor differentiation that does not exist in late lineage restricted progenitors or mature cells. Our previous studies showed that the loss of PTPMT1 also blocked ESC differentiation without impacting the function of mature embryonic fibroblasts (Shen et al., 2011) . It seems that the bioenergetic stress-activated differentiation-controlling mechanism is well conserved between embryonic and somatic stem cells. Similar to HSC differentiation, ESC differentiation also requires a tremendous energy supply, which relies on a robust and rapid upregulation of mitochondrial activities. Unlike HSCs, however, ESCs also require substantial mitochondrial biogenesis for differentiation because the mitochondrial mass in ESCs is significantly lower than that in differentiated cells (Cho et al., 2006; Lonergan et al., 2007) . Another interesting finding in this report is that although mitochondrial metabolism in PTPMT1-depleted stem cells was only moderately perturbed, the cellular responses (cell cycle changes and differentiation block) were rather profound. This phenomenon is reminiscent of conditions involving nuclear DNA damage, or mitotic spindle assembly checkpoints, in which a single double-strand DNA break or misalignment of a single chromosome causes complete cell cycle arrest (Musacchio and Salmon, 2007; Reinhardt and Yaffe, 2009 ). The mitochondrial bioenergetic stress signal elicited by PTPMT1 ablation appears to be propagated and amplified through the p53-p21/ p57 pathway, similar to the DNA-damage-induced cell cycle checkpoint. Cyclin-dependent kinase inhibitors, p21 and p57, were significantly upregulated, and p53 was moderately upregulated in PTPMT1 knockout stem cells and early progenitors (Figure 5F ). As the energy stress sensor AMPK was highly activated in these cells (Figures 6F and 6G ) and activation of AMPK has been demonstrated to induce p53-dependent cell cycle arrest (Imamura et al., 2001; Jones et al., 2005) , it is likely that the altered mitochondrial metabolism caused by PTPMT1 deficiency is sensed by AMPK and then relayed to the p53-p21/ p57 pathway.
PTPMT1 deficiency appears to exert its deleterious effects by disrupting PIP homeostasis in the mitochondria. PTPMT1 is localized to the inner membrane (Pagliarini et al., 2005) and breaks down PIPs (Pagliarini et al., 2004; Shen et al., 2011) . Its catalytic activity and mitochondrial localization were required for HSC differentiation (Figure 4) . Furthermore, overloading of PIP substrates, such as PI(3,5)P 2 , in WT LSK cells decreased mitochondrial oxygen consumption ( Figure 7A ), recapitulating the metabolic changes seen in PTPMT1-depleted LSK cells (Figure 6D) . In contrast, inhibition of PI(3,5)P 2 production by the PIKfyve inhibitor partially restored differentiation capabilities of PTPMT1 knockout HSCs ( Figures 7E and 7F ). More importantly, PIP substrates of PTPMT1 directly enhanced fatty-acid-induced activation of mitochondrial UCP2 in in vitro proteoliposome assays ( Figures 7C and 7D ). Since UCP2 inhibits glucosederived pyruvate oxidation in mitochondria (Bouillaud, 2009; Diano and Horvath, 2012; Samudio et al., 2009 ) and cellular differentiation may be intimately tied to the balance between glucose and fatty acid oxidation (Pearce et al., 2009; Zhang et al., 2011b) , one intriguing hypothesis is that the build-up of PIP substrates in PTPMT1-depleted mitochondria enhances UCP2 function and thereby critically alters mitochondrial substrate utilization within the stem cell, leading to bioenergetic stress and differentiation block. Further studies will be essential to determine the structural bases of the interactions between PIPs and UCP2, how PTPMT1 might regulate other aspects of UCP-mediated physiology, and whether PTPMT1 plays a similar role in other tissue-specific stem cells.
EXPERIMENTAL PROCEDURES Apoptosis and Cellular ROS Level Measurement
Fresh BM cells were stained with biotin-labeled antibodies against lineage markers (Gr-1, Mac-1, B220, Ter119, CD4, CD8, and CD3e) and then stained with Streptavidin eFluorÒ 450 and antibodies labeled with various fluorochromes (anti-c-Kit-APC-Cy7, anti-Sca-1-PE-Cy7, anti-CD150-APC, and anti-CD48-PE) purchased from BD Biosciences (San Jose, CA) or eBiosciences, Inc. (San Diego, CA). The cells were then stained with Annexin V-FITC and 7-amino-actinomycin D (7-AAD) using an Annexin V-FITC apoptosis Detection Kit I (BD Biosciences). Apoptotic cells in the gated HSC (Lineage À Sca-1 + c-
) population were quantified by FACS. To measure cellular ROS levels, cells were loaded with 2 0 -7 0 -dichlorofluorescein diacetate (DCF-DA) (5 mM) at 37 C for 15 min after being stained with the antibodies described as above. ROS (H 2 O 2 ) levels in the gated HSC population were quantified using flow cytometry.
Cell Cycle Analysis
To analyze the cell cycle status of LSK cells, fresh BM cells were stained with Pyronin Y (1 mg/ml) and Hoechst 33342 (10 mg/ml). The cells were washed and then stained with antibodies labeled with various fluorochromes (anti-lineages-APC-Cy7 [Gr-1, Mac-1, B220, Ter119, CD4, CD8, and CD3e], anti-cKit-APC, and anti-Scal-1-PE-Cy7). Subsequent cell population gating and quantification of the cells at G 0 , G 1 , and S/G 2 /M phases by FACS were performed as previously reported (Xu et al., 2011; Xu et al., 2010 ) were sorted and deposited into 75% ethanol. Cells were fixed at À20 C for 24 hr and then stained with FITC-labeled anti-Ki67 antibody (BD Biosciences) followed by propidium iodide (PI) (50 mg/ml). Percentages of the cells at G 0 , G 1 , and S/ G 2 /M phases were quantified by FACS.
Oxygen Consumption and ATP Measurement
Measurement of intact cellular respiration was performed using the Seahorse XF24 and XF96 analyzers as previously described (Liu et al., 2009 ) were sorted into PBS and assessed using a CellTiter-GloÒ Luminescent Cell Viability Assay kit (Promega Corporation, Madison, WI), which is a homogeneous method to determine the number of viable cells in culture based on quantitation of the ATP present.
Reconstitution of UCP2 in Liposomes, Formation of UCP2-Containing Planar Bilayer, and Proton Conductance Measurement Human recombinant UCP2 was purified from E. coli inclusion bodies and reconstituted into liposomes using a previously described protocol (Beck et al., 2007; Rupprecht et al., 2010) . To introduce arachidonic acid (AA) and/ or PIPs, proteoliposomes were mixed with AA-or PIP-containing liposomes in required proportions. Planar lipid bilayers were formed from proteoliposomes on the tip of plastic pipettes as previously described (Beck et al., 2006) . Current-voltage (I-V) characteristics were measured by a patch-clamp amplifier (EPC 10, HEKA Elektronik Dr. Schulze GmbH, Germany). Total membrane conductance was determined from a linear fit of experimental data (I) at applied voltages ranging from À50 to 50 mV as described previously (Rupprecht et al., 2010) .
Statistical Analysis
Statistical significance was determined using unpaired two-tailed Student's t test. p < 0.05 was considered to be significant.
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